CO2022015018A2 - Métodos y medios para modificar la hemodinámica en infecciones - Google Patents

Métodos y medios para modificar la hemodinámica en infecciones

Info

Publication number
CO2022015018A2
CO2022015018A2 CONC2022/0015018A CO2022015018A CO2022015018A2 CO 2022015018 A2 CO2022015018 A2 CO 2022015018A2 CO 2022015018 A CO2022015018 A CO 2022015018A CO 2022015018 A2 CO2022015018 A2 CO 2022015018A2
Authority
CO
Colombia
Prior art keywords
infection
hemodynamics
infections
modify
methods
Prior art date
Application number
CONC2022/0015018A
Other languages
English (en)
Spanish (es)
Inventor
Gert Wensvoort
Eric Claassen
Johan Renes
Original Assignee
Biotempt Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotempt Bv filed Critical Biotempt Bv
Publication of CO2022015018A2 publication Critical patent/CO2022015018A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CONC2022/0015018A 2020-04-06 2022-10-21 Métodos y medios para modificar la hemodinámica en infecciones CO2022015018A2 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063005999P 2020-04-06 2020-04-06
US202063045737P 2020-06-29 2020-06-29
US202063085771P 2020-09-30 2020-09-30
PCT/NL2021/050223 WO2021206547A1 (en) 2020-04-06 2021-04-06 Methods and means for modifying hemodynamics in infections

Publications (1)

Publication Number Publication Date
CO2022015018A2 true CO2022015018A2 (es) 2022-10-31

Family

ID=75581581

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0015018A CO2022015018A2 (es) 2020-04-06 2022-10-21 Métodos y medios para modificar la hemodinámica en infecciones

Country Status (9)

Country Link
US (1) US20230241155A1 (https=)
EP (1) EP4132556A1 (https=)
JP (2) JP2023521744A (https=)
KR (1) KR20230003495A (https=)
AU (1) AU2021252821A1 (https=)
CA (1) CA3174852A1 (https=)
CO (1) CO2022015018A2 (https=)
MX (1) MX2022012506A (https=)
WO (1) WO2021206547A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
AU2021354766A1 (en) * 2020-09-30 2023-05-11 Biotempt B.V. Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability
WO2025191033A1 (en) 2024-03-13 2025-09-18 Biotempt B.V. Per-operative treatment of post-operative complications (poc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542791A (en) * 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
CA3152346A1 (en) * 2019-09-30 2021-04-08 Roelof Peter Pickkers Methods of treatment for modifying hemodynamics

Also Published As

Publication number Publication date
JP2026027378A (ja) 2026-02-18
MX2022012506A (es) 2023-01-16
EP4132556A1 (en) 2023-02-15
WO2021206547A1 (en) 2021-10-14
KR20230003495A (ko) 2023-01-06
JP2023521744A (ja) 2023-05-25
CA3174852A1 (en) 2021-10-14
US20230241155A1 (en) 2023-08-03
AU2021252821A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
CO2022015018A2 (es) Métodos y medios para modificar la hemodinámica en infecciones
DOP2023000187A (es) Anticuerpos que se dirigen al gp120 de vih y métodos de uso
JOP20200156A1 (ar) إيسكيتامين لعلاج الاكتئاب
MX2022011671A (es) Vacunas contra el coronavirus y metodos de uso.
CL2020002512A1 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak.
MX2020009856A (es) Rimegepant para trastornos relacionados con el peptido relacionado con el gen para calcitonina (cgrp).
MX388408B (es) Tratamiento combinado con un agonista de tlr7 y un inhibidor de montaje de capsida de hbv
AR062453A1 (es) Metodo de terapia combinada para el tratamiento de la infeccion por el virus de la hepatitis c y composiciones farmaceuticas para usar en dicha terapia
EA202090564A1 (ru) Способы усиления и/или стабилизации сердечной функции у пациентов с болезнью фабри
CL2022000786A1 (es) Metodos de tratamiento para modificar la hemodinamica
CL2021000924A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
ECSP17019893A (es) Tratamientos médicos a base de anamorelina
MX2022014034A (es) Métodos para tratar covid-19 con el uso de bardoxolona metilo o análogos de esta.
AR119159A1 (es) Tratamientos de angioedema
WO2019010301A8 (en) Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
WO2021184128A8 (en) Methods of treating a coronavirus infection using colchicine
CO2025004675A2 (es) Método para tratar vih con cabotegravir y rilpivirina en pacientes pediátricos
MX2022013722A (es) Cisteamina para el tratamiento de infección por sars-cov-2.
MX2022011138A (es) Efecto contra coronavirus y aplicacion de inhibidor de fosfatidilinositol 4-cinasa.
MX2022007738A (es) Procesos e intermedios sinteticos.
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
ZA202206123B (en) Methods of treating hiv-1 infection
JP1825332S (ja) 診療用椅子
JP1735109S (ja) 医療用電極